Conclusion: Our findings showed that GDNP treatment can prevent HFD-induced obesity and insulin resistance via protecting the Foxa2 from Akt-1 mediated phosphorylation. The gene discussed is FOXA2; the disease is obesity due to melanocortin 4 receptor deficiency.